Statements from the Taormina expert meeting on occult hepatitis B virus infection.
about
Genetic variation of occult hepatitis B virus infectionKASL clinical practice guidelines: management of chronic hepatitis BGenetic variation of hepatitis B virus and its significance for pathogenesisAsymptomatic Hepadnaviral Persistence and Its Consequences in the Woodchuck Model of Occult Hepatitis B Virus InfectionHepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendationsRole of occult hepatitis B virus infection in chronic hepatitis CManagement of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelinesOccult hepatitis B virus infectionClinical impact of occult hepatitis B virus infection in immunosuppressed patientsMolecular mechanisms underlying occult hepatitis B virus infection.Update on occult hepatitis B virus infectionDiagnosis of hepatitis BThe clinical implications of hepatitis B virus genotypes and HBeAg in pediatricsGenotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern AfricaPrediction of conformational changes by single mutation in the hepatitis B virus surface antigen (HBsAg) identified in HBsAg-negative blood donorsVirologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipientsOccult HBV infection: a faceless enemy in liver cancer development.Occult Hepatitis B Virus Infection among HIV Positive Patients in NigeriaMolecular characteristics of occult hepatitis B virus from blood donors in southeast China.Hepatitis B serological markers and plasma DNA concentrations.Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global populationChronic hepatitis B: Advances in treatment.Occult hepatitis B virus and hepatocellular carcinomaSequence variations of full-length hepatitis B virus genomes in Chinese patients with HBsAg-negative hepatitis B infection.Occult hepatitis B in blood donors in Indonesia: altered antigenicity of the hepatitis B virus surface proteinOccult hepatitis B virus infection in HIV positive patients at a tertiary healthcare unit in eastern IndiaEpidemiology of acute and chronic hepatitis B and delta over the last 5 decades in ItalyClinical implications of hepatitis B virus mutations: recent advances.Hepatitis B and hepatitis C viral infections in patients with chronic lymphocytic leukemiaMolecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapyMolecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, ChinaOccult hepatitis B viral infection among blood donors in South-Eastern NigeriaThe intracellular HBV DNAs as novel and sensitive biomarkers for the clinical diagnosis of occult HBV infection in HBeAg negative hepatocellular carcinoma in China.Occult hepatitis B virus infection among Mexican human immunodeficiency virus-1-infected patients.Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapyHepatitis B virus and hepatitis C virus dual infection.Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt--that is the question.Rare detection of occult hepatitis B virus infection in children of mothers with positive hepatitis B surface antigenOccult hepatitis B virus infection in liver transplant patients in a Brazilian referral center
P2860
Q26751031-FACAF787-2259-4BD4-9123-98097AF15D22Q26752475-1E0CF57C-6A5B-41BD-861A-341F74FBC034Q26772348-FB4B5FA8-A03D-4BAF-B9F3-DDCFD71B7B60Q26775638-56438977-67DF-4FDB-A995-EF151E17AF7CQ26784247-9D0A6D94-31DE-452B-937C-6871C2D397ABQ26823538-566AA68B-0DA3-45F6-B76F-25EA5C731862Q27000080-F88EE4AB-E6F3-4999-9CB5-CAC63F79CA96Q27004224-152D3BB4-D1FE-47ED-A189-44AE8A519AC2Q27006996-BE11D42F-A5F3-4B69-AAB2-930A2E97633BQ27686923-DED07E52-FC7D-44C6-B4E1-83E4E83D0A0DQ28070317-191774BF-66FD-4BAC-A0DB-07D2FFD8F320Q28071817-1BD9CEB9-8C49-4882-B400-83FF8DFEE339Q28073299-A8D5C754-BC7E-44B8-867D-B01CCBF520D4Q28484102-87333277-C5D9-4D28-8101-2EF73C7A5CE4Q30396406-F6F7126D-E21E-4FDF-B879-7704AD05C822Q30431051-58018AA9-A686-4FD9-B926-DD079F46721CQ33584773-52BC07FC-F858-42EE-81CC-8F741D8F62ECQ33607322-1C71AEB5-F691-459E-A04C-ADD6D460049BQ33627411-B298A6CE-AE30-46BB-AC17-BC25E15890A3Q33631046-AFBA316E-A4EB-4BAF-903D-3167C93BE9ADQ33637292-C6A8399D-5092-48C6-9B11-DD02D8F8127CQ33660010-BCBBEBA9-3048-41CD-83AC-FA2123C6B4B0Q33661018-4F25A982-C8E2-43A8-ADDB-CA0814731DD3Q33717096-753F78CB-91E8-4E15-91CA-08DEFE99CC9BQ33743076-6863E66F-4B87-45F5-9FAD-8C202C619B58Q33773235-C35D56EC-5DBF-43D1-9AB3-E2B6F5B5F175Q33801300-3FCA8F5D-BD08-48EB-BD86-13753683EDFEQ33801311-D68BC920-EDF5-41DD-BB3B-799A92F03CD5Q33810030-10070FB7-032E-41F5-95B0-53973485F2A4Q34067400-2036912D-C512-499B-BFDF-B1F24D0E4FC9Q34080966-79CF32D8-2227-4574-956E-66413DE1CE69Q34097882-01CEBCD3-0335-4F62-B18B-B5906FC5EC52Q34129673-7A743533-8298-4C27-8D9E-2B38BA305170Q34206628-74D38E85-DB4E-455E-946E-6697FF49F155Q34303032-21E70671-EB90-4104-9A0B-1CAC58E77B22Q34387913-8BEF7444-7134-4DF1-8BCB-85F1363E6730Q34404975-904FBD27-4CCE-4AA4-992D-51E06EC0F540Q34437586-6AB90290-817B-474C-8D75-AE32B3BC57C1Q34483190-9608F919-B003-4A36-B2AA-C580ECC2B413Q34502631-DF06DF12-8520-4DE8-A418-C2758730049B
P2860
Statements from the Taormina expert meeting on occult hepatitis B virus infection.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Statements from the Taormina expert meeting on occult hepatitis B virus infection.
@en
Statements from the Taormina expert meeting on occult hepatitis B virus infection.
@nl
type
label
Statements from the Taormina expert meeting on occult hepatitis B virus infection.
@en
Statements from the Taormina expert meeting on occult hepatitis B virus infection.
@nl
prefLabel
Statements from the Taormina expert meeting on occult hepatitis B virus infection.
@en
Statements from the Taormina expert meeting on occult hepatitis B virus infection.
@nl
P2093
P50
P1476
Statements from the Taormina expert meeting on occult hepatitis B virus infection.
@en
P2093
Alessandro R Zanetti
Antonina Smedile
Christian Trépo
Daniel Shouval
Fabien Zoulim
Francesco Donato
Giovanni B Gaeta
Giovanni Raimondo
Giovanni Squadrito
P304
P356
10.1016/J.JHEP.2008.07.014
P50
P577
2008-07-31T00:00:00Z